• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].

作者信息

Beyer J, Liebau G, Steiner B, Hayduk K

出版信息

Klin Wochenschr. 1978 Sep 1;56(17):859-64. doi: 10.1007/BF01479836.

DOI:10.1007/BF01479836
PMID:713415
Abstract

In 34 patients saralasin was infused after variable degrees of sodium depletion in order to differentiate between essential and renin-induced hypertension. After sodium-depletion of short duration mean arterial pressure dropped more than 10 mm Hg in 9 of 25 patients with essential and in 7 of 9 patients with renin-induced hypertension. After long-lasting sodium depletion the fall of mean arterial pressure exceeded 10 mm Hg in 11 of 16 patients with essential and in 8 of 9 patients with renin-induced hypertension. Thus saralasin did not discriminate essential and renin-induced hypertension. Also, plasma renin concentration before and after saralasin did not allow to differentiate between the two forms of hypertension. The changes of renin during infusion of saralasin was negatively correlated to the change of blood pressure. Renal vein renin ratio in patients with renovascular hypertension was not modified by saralasin. Renin and aldosterone changed inversely during saralasin infusion.

摘要

相似文献

1
[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
Klin Wochenschr. 1978 Sep 1;56(17):859-64. doi: 10.1007/BF01479836.
2
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.血管紧张素II拮抗剂沙拉新对正常人和高血压患者血压及肾素-血管紧张素-醛固酮系统的影响。
Aust N Z J Med. 1976 Aug;6(3 Suppl):48-52. doi: 10.1111/j.1445-5994.1976.tb03335.x.
3
Saralasin infusion in the recognition of renovascular hypertension.
Ann Intern Med. 1977 Jul;87(1):36-42. doi: 10.7326/0003-4819-87-1-36.
4
[Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].沙拉新对正常血压及肾血管性高血压的作用(作者译)
Dtsch Med Wochenschr. 1976 Mar 12;101(11):398-401. doi: 10.1055/s-0028-1104095.
5
[Clinical usefulness of saralasin in human hypertension (author's transl)].沙拉新在人类高血压中的临床应用(作者译)
Nouv Presse Med. 1978 Feb 18;7(7):539-43.
6
Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.1-去氨基-8-右旋-丙氨酸血管紧张素II对高血压患者动脉血压、肾素及醛固酮的影响
Contrib Nephrol. 1978;11:175-8. doi: 10.1159/000401800.
7
[Saralasin for renovascular or essential hypertension (author's transl)].沙拉新用于肾血管性或原发性高血压(作者译)
Dtsch Med Wochenschr. 1978 Nov 10;103(45):1790-6. doi: 10.1055/s-0028-1129344.
8
[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
Klin Wochenschr. 1977 Jul 1;55(13):651-6. doi: 10.1007/BF01482536.
9
Saralasin infusion in renovascular and essential hypertension.血管紧张素Ⅱ四肽(沙拉新)输注治疗肾血管性高血压和原发性高血压
Neth J Med. 1980;23(2):68-73.
10
The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.血管紧张素II拮抗剂沙拉新对人体血压和血浆醛固酮的影响与当时血浆血管紧张素II浓度的关系。
Prog Biochem Pharmacol. 1976;12:230-41.

本文引用的文献

1
Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension.双侧肾静脉肾素测定。其在肾血管性高血压诊断中的应用。
Arch Intern Med. 1967 Oct;120(4):444-8.
2
Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate.人血浆中肾素“浓度”和“活性”的改进测定方法。采用肾素底物选择性变性的方法。
Circ Res. 1967 Apr;20(4):391-402. doi: 10.1161/01.res.20.4.391.
3
Clinical characteristics of renovascular hypertension.肾血管性高血压的临床特征
JAMA. 1972 May 29;220(9):1209-18.
4
Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability.肾血管性高血压:测量肾素以指示分泌过多和对侧抑制,估计肾血浆流量,并评估手术可治愈性。
Am J Med. 1973 Sep;55(3):402-14. doi: 10.1016/0002-9343(73)90139-3.
5
Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism.通过血管紧张素I免疫测定法测定血浆肾素浓度。原发性醛固酮增多症中肾素水平低于正常时精确测量的诊断意义。
Circ Res. 1971 May;28(5):Suppl 2:175-91. doi: 10.1161/01.res.28.5.ii-175.
6
Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.在正常男性中用1- Sar,8- Ala血管紧张素II阻断和刺激肾、肾上腺及血管的血管紧张素II受体。
J Clin Invest. 1976 Jan;57(1):39-46. doi: 10.1172/JCI108266.
7
Experience with renal vein renin ratios in the identification of a pressor kidney.肾静脉肾素比值在识别加压肾方面的经验。
South Med J. 1975 Oct;68(10):1200-6. doi: 10.1097/00007611-197510000-00006.
8
Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).
Circ Res. 1975 Jun;36(6 Suppl 1):125-32. doi: 10.1161/01.res.36.6.125.
9
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.血管紧张素II部分竞争性激动剂沙拉新在评估高血压患者肾素和钠因素方面的作用及局限性
Am J Med. 1976 May 31;60(6):825-36. doi: 10.1016/0002-9343(76)90903-7.
10
Angiotensin blockade: its clinical significance.
Am J Med. 1976 May 31;60(6):817-24. doi: 10.1016/0002-9343(76)90894-9.